Filing Details

Accession Number:
0001127602-21-002274
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-21 17:17:00
Reporting Period:
2021-01-19
Accepted Time:
2021-01-21 17:17:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
64803 Cvs Health Corp CVS Retail-Drug Stores And Proprietary Stores (5912) 050494040
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1194413 J Larry Merlo One Cvs Drive
Woonsocket RI 02895-
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-19 64,350 $74.29 586,222 No 4 M Direct
Common Stock Disposition 2021-01-19 62,893 $77.00 523,329 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2021-01-19 64,350 $0.00 64,350 $74.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
271,347 2015-04-01 2021-04-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 403,808 Indirect By Trust As Beneficiary
Common Stock (Restricted) 40,701 Direct
Esop Common Stock 7,304 Indirect By ESOP
Stock Unit 684,489 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Phantom Stock Credits $1.00 5,152 5,152 Direct
Common Stock Stock Option $102.26 2016-04-01 2022-04-01 273,929 273,929 Direct
Common Stock Stock Option $104.82 2017-04-01 2023-04-01 286,787 286,787 Direct
Common Stock Stock Option $78.05 2018-04-03 2024-04-03 338,105 338,105 Direct
Common Stock Stock Option $62.21 2019-04-01 2025-04-01 394,091 394,091 Direct
Common Stock Stock Option $54.19 2020-04-01 2029-04-01 545,419 545,419 Direct
Common Stock Stock Option $58.34 2021-04-01 2030-04-01 478,711 478,711 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
5,152 5,152 Direct
2022-04-01 273,929 273,929 Direct
2023-04-01 286,787 286,787 Direct
2024-04-03 338,105 338,105 Direct
2025-04-01 394,091 394,091 Direct
2029-04-01 545,419 545,419 Direct
2030-04-01 478,711 478,711 Direct
Footnotes
  1. All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.
  2. Option became exercisable in four equal annual installments, commencing 4/1/2015.
  3. Each share credit is equivalent to one share; 1-for-1 conversion.
  4. Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  5. Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  6. Option became exercisable in four equal annual installments, commencing 4/1/2016.
  7. Option became exercisable in four equal annual installments, commencing 4/1/2017.
  8. Option became exercisable in four equal annual installments, commencing 4/3/2018.
  9. Option became exercisable in four equal annual installments, commencing 4/1/2019.
  10. Option became exercisable in four equal annual installments, commencing 4/1/2020.
  11. The number of shares subject to the option were calculated using a 30-day average price.
  12. Option becomes exercisable in four equal annual installments, commencing 4/1/2021.